Literature DB >> 9709877

Oropharyngeal candidiasis as a marker for esophageal candidiasis in patients with cancer.

G Samonis1, P Skordilis, S Maraki, G Datseris, P Toloudis, I Chatzinikolaou, V Georgoulias, G P Bodey.   

Abstract

The present study was designed to determine the frequency of candidal esophagitis in cancer patients with oral thrush. Patients with clinically and microbiologically diagnosed oral candidiasis were evaluated by endoscopy for concurrent esophageal candidiasis. Esophageal involvement was documented by mucosal lesions, microbiological findings of candidal infection in smears of brushing material, positive cultures of brushing material, and histological evidence of mucosal invasion by the yeast. For 21 of the 22 patients studied, there were endoscopic and microbiological findings of candidal esophagitis. Cultures of the brushing material from all 22 patients were positive, while histological evidence was found for 14 patients. Only 10 of the patients had mild esophageal symptoms. It is concluded that oral thrush represents a reliable marker for esophageal candidiasis in patients with cancer. Routine endoscopy is not necessary to confirm the diagnosis; this procedure should be reserved for patients with persistent thrush and symptoms despite antifungal therapy.

Entities:  

Mesh:

Year:  1998        PMID: 9709877     DOI: 10.1086/514653

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  4 in total

Review 1.  Etiology, diagnosis and treatment of infectious esophagitis.

Authors:  Mariusz Rosołowski; Maciej Kierzkiewicz
Journal:  Prz Gastroenterol       Date:  2013-12-30

2.  Possible Risk Factors for Candida Esophagitis in Immunocompetent Individuals.

Authors:  Yousef Nassar; Tony Eljabbour; Hwajeong Lee; Asra Batool
Journal:  Gastroenterology Res       Date:  2018-05-31

3.  Burden of Serious Fungal Infections in Jordan.

Authors:  Jamal Wadi; David W Denning
Journal:  J Fungi (Basel)       Date:  2018-01-18

4.  Candidemia in immunocompromised and immunocompetent critically ill patients: a prospective comparative study.

Authors:  G Dimopoulos; A Karabinis; G Samonis; M E Falagas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-06       Impact factor: 3.267

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.